Clinical study on cognitive impairment in Duchenne muscular dystrophy

被引:4
|
作者
Zhang, Xiao-Fang [1 ]
Luo, Yuan-Yuan [1 ]
Jiang, Li [1 ]
Hong, Si-Qi [1 ,2 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Natl Clin Res Ctr Child Hlth & Disorders,China Int, Dept Neurol,Minist Educ,Key Lab Child Dev & Disord, Chongqing, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, 2nd Zhongshan Rd, Chongqing, Peoples R China
关键词
Duchenne muscular dystrophy; Dystrophin; Cognitive impairment; Glucocorticoids; MEMORY; PERFORMANCE; TRANSCRIPT; CHILDREN; GENE; DP71;
D O I
10.1016/j.nmd.2023.06.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Our study aimed to explore the intellectual function of patients with Duchenne muscular dystrophy (DMD) in China and examine the correlation of full-scale intelligence quotient (FSIQ) with age, mutation locations, mutation class, and dystrophin isoforms. We assessed 64 boys with DMD using The Wechsler Intelligence Scales for Children-Fourth Edition and compared intellectual function at enrollment and follow-up in the 15 patients who completed the follow-up. Our findings confirm that boys with DMD may exhibit cognitive impairment, with the Working Memory Index being the most impaired. There was no significant correlation between FSIQ and age; however, a positive correlation was noted between age and the Verbal Comprehension Index. FSIQ was not associated with mutation class, the number of affected mutated exons, or mutation locations. However, there was a significant difference in FSIQ between the groups with intact and deficient Dp140. Fifteen participants adhered to glucocorticoid therapy throughout the two-year follow-up period, and eleven of them showed an improvement in FSIQ compared to their initial scores, with improvement ranging from 2 to 20. In conclusion, patients with the cumulative loss of isoforms in the brain are at a higher risk of cognitive deficits and may require early cognitive interventions.& COPY; 2023 Elsevier B.V. All rights reserved.
引用
收藏
页码:596 / 604
页数:9
相关论文
共 50 条
  • [41] Orofacial dysfunction in Duchenne muscular dystrophy
    Botteron, Sebastien
    Verdebout, Catherine Morel
    Jeannet, Pierre-Yves
    Kiliaridis, Stavros
    ARCHIVES OF ORAL BIOLOGY, 2009, 54 (01) : 26 - 31
  • [42] Outcome Measures in Duchenne Muscular Dystrophy
    Benemei, Silvia
    Gatto, Francesca
    Boni, Luca
    Pane, Marika
    ACTA NEUROLOGICA BELGICA, 2024,
  • [43] The Duchenne muscular dystrophy gene and cancer
    Leanne Jones
    Michael Naidoo
    Lee R. Machado
    Karen Anthony
    Cellular Oncology, 2021, 44 : 19 - 32
  • [44] Cardiac asynchrony in Duchenne muscular dystrophy
    Abdallah Fayssoil
    Olivier Nardi
    David Orlikowski
    Djillali Annane
    Journal of Clinical Monitoring and Computing, 2013, 27 : 587 - 589
  • [45] THE ROLE OF MITOCHONDRIA IN DUCHENNE MUSCULAR DYSTROPHY
    Budzinska, M.
    Zimna, A.
    Kurpisz, M.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 72 (02): : 1 - 10
  • [46] CRISPR Therapeutics for Duchenne Muscular Dystrophy
    Erkut, Esra
    Yokota, Toshifumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [47] Lifetime Care of Duchenne Muscular Dystrophy
    MacKintosh, Erin W.
    Chen, Maida L.
    Benditt, Joshua O.
    SLEEP MEDICINE CLINICS, 2020, 15 (04) : 485 - +
  • [48] Gene therapy for Duchenne muscular dystrophy
    Ramos, Julian
    Chamberlain, Jeffrey S.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (11): : 1255 - 1266
  • [49] Nutrition Considerations in Duchenne Muscular Dystrophy
    Davis, Jillian
    Samuels, Emily
    Mullins, Lucille
    NUTRITION IN CLINICAL PRACTICE, 2015, 30 (04) : 511 - 521
  • [50] Cardiac asynchrony in Duchenne muscular dystrophy
    Fayssoil, Abdallah
    Nardi, Olivier
    Orlikowski, David
    Annane, Djillali
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2013, 27 (05) : 587 - 589